Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 May;84(5):506-11.
doi: 10.1136/bjo.84.5.506.

Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study

Affiliations

Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study

C H Kon et al. Br J Ophthalmol. 2000 May.

Abstract

Aim: To assess clinical variables and vitreous protein as risk factors for the development of postoperative proliferative vitreoretinopathy (PVR).

Methods: A prospective study was conducted on 140 patients with a rhegmatogenous retinal detachment in whom a primary vitrectomy was performed. 12 clinical variables were recorded and vitreous samples obtained for measurement of protein concentration. Univariate and multivariate logistic regression analysis was used to determine the risk factors for PVR.

Results: Complete data were available for 136 of 140 patients. 40 of the 136 patients (29.4%) developed postoperative PVR. Univariate regression revealed that significant (p<0.05) risk factors included aphakia, presence of preoperative PVR, size of detachment, the use of silicone oil, and high vitreous protein level. Multivariate regression analysis revealed only aphakia (odds ratio 2.72), the presence of preoperative PVR (odds ratio 3.01), and high vitreous protein concentration (odds ratio 1.11) to be significant (p<0.05) independent, predictive risk factors for the development of PVR.

Conclusions: This study has shown that the significant risk factors for PVR are preoperative PVR, aphakia, and high vitreous protein levels. Two models (clinical factors only and clinical factors and vitreous protein) were constructed to predict the probability of developing postoperative PVR and may be used to identify those at risk for possible intravitreal pharmacological treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scatter plot (sunflower) of visual acuity. CF = counting fingers, HM = hand movements, Pl = perception of light, NPL = no perception of light. Each sunflower petal represents one case.
Figure 2
Figure 2
Cumulative percentage of patients who developed postoperative PVR and the relation to vitreous protein. *Highest level of vitreous protein detected.

References

    1. Arch Ophthalmol. 1967 Jul;78(1):16-22 - PubMed
    1. J Fr Ophtalmol. 1994;17(8-9):530-40 - PubMed
    1. Arch Ophthalmol. 1979 Mar;97(3):480-3 - PubMed
    1. Invest Ophthalmol Vis Sci. 1994 Dec;35(13):4260-7 - PubMed
    1. Int Ophthalmol. 1994;18(2):53-60 - PubMed

Publication types